Volume | 38,503 |
|
|||||
News | - | ||||||
Day High | 1.52 | Low High |
|||||
Day Low | 1.47 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
UNITY Biotechnology Inc | UBX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.47 | 1.47 | 1.52 | 1.50 | 1.48 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
440 | 38,503 | US$ 1.50 | US$ 57,635 | - | 1.46 - 3.82 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
16:50:29 | 1 | US$ 1.52 | USD |
UNITY Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
22.22M | 14.62M | - | 0 | -39.86M | -2.73 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
UNITY Biotechnology News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UBX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.51 | 1.52 | 1.46 | 1.48 | 50,555 | -0.01 | -0.66% |
1 Month | 1.65 | 1.67 | 1.46 | 1.53 | 57,976 | -0.15 | -9.09% |
3 Months | 1.71 | 2.02 | 1.46 | 1.67 | 93,202 | -0.21 | -12.28% |
6 Months | 1.66 | 2.26 | 1.46 | 1.77 | 94,690 | -0.16 | -9.64% |
1 Year | 2.10 | 3.82 | 1.46 | 2.36 | 112,761 | -0.60 | -28.57% |
3 Years | 50.30 | 53.00 | 1.46 | 12.76 | 742,589 | -48.80 | -97.02% |
5 Years | 79.70 | 154.40 | 1.46 | 28.85 | 669,883 | -78.20 | -98.12% |
UNITY Biotechnology Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. |